Renal hemodynamics and hypertension during pregnancy
妊娠期肾脏血流动力学和高血压
基本信息
- 批准号:10090619
- 负责人:
- 金额:$ 38.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdenosineAreaBlood Plasma VolumeBlood PressureCardiac OutputCellsChronicDataDevelopmentDilatation - actionEtiologyExcretory functionFeedbackGenerationsGlomerular Filtration RateHormonesHypertensionImpairmentIschemiaKidneyMacula densaMeasuresMediatingModelingMusNOS1 geneNatriuresisNeonatal MortalityNephronsNeuronsNitric OxidePathologicPerfusionPeripheral ResistancePhysiologicalPhysiological AdaptationPlacentaPlasmaPlayPre-EclampsiaPregnancyPreventionProcessProteinuriaRNA SplicingRegulationRelaxinRenal Blood FlowRoleSodiumTelemetryTestingTubular formationUterusVariantVasodilationWaterWild Type Mousearteriolecorpus luteumfetalhemodynamicsneonatal morbiditynovelpregnantpressurerelease factorresponsetherapeutic target
项目摘要
Normal pregnancy involves extensive and systemic physiological adaptations characterized by substantial
volume expansion and vasodilatation. The exact mechanisms for the physiological changes have not been fully
clarified, but relaxin (a corpus luteum-released hormone) has been found to play a central role in the control of
hemodynamics in normal pregnancy. Inappropriate or inadequate adaptations during pregnancy may induce
pathological consequences such as preeclampsia, which is characterized by new-onset hypertension and
proteinuria after 20 weeks of gestation. Renal hemodynamic alterations during preeclampsia are characterized
by reduced GFR and RBF by about 20-40% compared with normal pregnancies. Non-selective nitric oxide
synthesis (NOS) inhibition not only blocks the elevations in GFR and RBF during normal pregnancy, but also
induces hypertension and proteinuria, suggesting the essential role of nitric oxide (NO) in control of the
hemodynamics in normal pregnancy and preeclampsia.
GFR is normally regulated by tubuloglomerular feedback (TGF) response. The significance of TGF response
in normal pregnancy and preeclampsia has not been elucidated. Specifically, whether the changes in TGF
response during normal pregnancy are a consequence of systemic vessel dilatation or the cause for the
increased GFR is unknown; whether the decreased GFR during preeclampsia is mediated by TGF
responsiveness, which induces or is a consequence of the development of hypertension is unknown; and
whether NOS1β in the macula densa mediates TGF alterations and triggers the development of hypertension
during preeclampsia is unknown. All of these unidentified areas will be explored in the present proposal.
We will test our hypothesis that NOS1β in the macula densa increases during normal pregnancy, which
blunts TGF responsiveness that contributes to maintaining increased GFR and decreased blood
pressure. During preeclampsia, factors that are released from the placenta decrease the macula densa
NOS1β expression and activity, which enhances TGF responsiveness. Elevations of GFR in pregnancy
are limited by the enhanced TGF response, which reduces sodium excretion, impairs pressure
natriuresis, and thereby induces hypertension.
正常妊娠涉及广泛的和系统的生理适应,其特征在于大量的
体积膨胀和血管舒张。生理变化的确切机制尚未完全阐明
澄清,但松弛素(黄体释放激素)已被发现在控制
正常妊娠的血流动力学。怀孕期间不适当或不充分的适应可能会导致
病理后果,如先兆子痫,其特征是新发高血压,
妊娠20周后出现蛋白尿。先兆子痫时肾血流动力学改变的特点是
与正常妊娠相比,GFR和RBF降低约20-40%。非选择性氧化氮
一氧化氮合酶(NOS)抑制不仅可以阻断正常妊娠期间GFR和RBF的升高,
诱导高血压和蛋白尿,提示一氧化氮(NO)在控制高血压和蛋白尿中的重要作用。
正常妊娠和先兆子痫血流动力学研究
GFR通常由肾小管肾小球反馈(TGF)反应调节。TGF反应的意义
在正常妊娠和先兆子痫中的作用尚未阐明。具体来说,TGF的变化是否
正常妊娠期间的反应是全身血管扩张的结果或导致
尚不清楚GFR升高;先兆子痫期间GFR降低是否由TGF-β 1介导
引起高血压或高血压发展的结果的反应性尚不清楚;以及
致密斑中的NOS 1 β是否介导TGF改变并触发高血压的发展
先兆子痫的发病率是未知的。本提案将探讨所有这些未确定的领域。
我们将检验我们的假设,即在正常妊娠期间致密斑中NOS 1 β增加,
减弱TGF反应性,有助于维持GFR增加和血流量减少
压力在先兆子痫期间,从胎盘释放的因子减少了致密斑,
NOS 1 β表达和活性增强TGF反应性。妊娠期GFR升高
受到增强的TGF反应的限制,这减少了钠排泄,损害了压力,
尿钠排泄,从而诱发高血压。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Sestrin2 Mediates Metformin Rescued the Age-Related Cardiac Dysfunctions of Cardiorenal Syndrome Type 3.
- DOI:10.3390/cells12060845
- 发表时间:2023-03-08
- 期刊:
- 影响因子:6
- 作者:Iglesias, Migdalia;Wang, Hao;Krause-Hauch, Meredith;Ren, Di;Zoungrana, Linda Ines;Li, Zehui;Zhang, Jie;Wei, Jin;Yadav, Nikita;Patel, Kshama;Fatmi, Mohammad Kasim;Liu, Ruisheng;Lesnefsky, Edward J.;Li, Ji
- 通讯作者:Li, Ji
Glucose dilates renal afferent arterioles via glucose transporter-1.
- DOI:10.1152/ajprenal.00409.2017
- 发表时间:2018-07
- 期刊:
- 影响因子:0
- 作者:Jie Zhang;Shan Jiang;Jin Wei;K. Yip;Lei Wang;E. Lai;Ruisheng Liu
- 通讯作者:Jie Zhang;Shan Jiang;Jin Wei;K. Yip;Lei Wang;E. Lai;Ruisheng Liu
Orthotopic Heart Auto-Transplantation in a Swine Model.
- DOI:10.4236/wjcs.2022.129017
- 发表时间:2022-09
- 期刊:
- 影响因子:0
- 作者:Rogers MP;Fishberger G;Martini N;Baldwin M;Wang L;Chen W;Liu R;Lozonschi L
- 通讯作者:Lozonschi L
Microvascular dysfunction and kidney disease: Challenges and opportunities?
- DOI:10.1111/micc.12661
- 发表时间:2021-04
- 期刊:
- 影响因子:0
- 作者:Krishnan S;Suarez-Martinez AD;Bagher P;Gonzalez A;Liu R;Murfee WL;Mohandas R
- 通讯作者:Mohandas R
The Role of Macula Densa Nitric Oxide Synthase 1 Beta Splice Variant in Modulating Tubuloglomerular Feedback.
- DOI:10.1002/cphy.c210043
- 发表时间:2023-01-30
- 期刊:
- 影响因子:5.8
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUISHENG LIU其他文献
RUISHENG LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUISHENG LIU', 18)}}的其他基金
Treatment of lupus nephritis with nanoparticles that selectively target kidney glomeruli
用选择性靶向肾小球的纳米颗粒治疗狼疮性肾炎
- 批准号:
10679184 - 财政年份:2023
- 资助金额:
$ 38.78万 - 项目类别:
Tubuloglomerular feedback response in AKI to CKD transition
AKI 向 CKD 转变中的肾小球反馈反应
- 批准号:
10533630 - 财政年份:2022
- 资助金额:
$ 38.78万 - 项目类别:
Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
- 批准号:
9917816 - 财政年份:2019
- 资助金额:
$ 38.78万 - 项目类别:
Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
- 批准号:
10394215 - 财政年份:2019
- 资助金额:
$ 38.78万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8895614 - 财政年份:2014
- 资助金额:
$ 38.78万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8692309 - 财政年份:2014
- 资助金额:
$ 38.78万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
8817288 - 财政年份:2014
- 资助金额:
$ 38.78万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
9282582 - 财政年份:2014
- 资助金额:
$ 38.78万 - 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
- 批准号:
9068089 - 财政年份:2014
- 资助金额:
$ 38.78万 - 项目类别:
Tubuloglomerular feedback and salt-sensitive hypertension
肾小球反馈和盐敏感性高血压
- 批准号:
9068087 - 财政年份:2013
- 资助金额:
$ 38.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.78万 - 项目类别:
Research Grant